CTNNB1 and breast cancer: Current research has shown that TMEM170B negatively regulates canonical Wnt signaling in breast cancer cells and exerts an inhibitory effect on breast cancer growth by inhibiting CTNNB1 stabilization and nucleus translocation, which reduces the activity of Wnt targets Li et al. (2018).